Determining Best Practice for Colonoscopy Preparation for Persons with Constipation by Smith, Michele Diane
Determining Best Practice for Colonoscopy Preparation for Persons with Constipation 
By 
 
Michele Diane Smith, BSN 
University of Kansas School of Nursing 
2019 
 
Submitted to the School of Nursing and The Graduate Faculty of the University of Kansas in 
partial fulfillment of the requirements for the degree of Doctor of Nursing Practice. 
Carol Buller DNP, FNP-BC, GNP-BC 
________________________________        
    Faculty Project Committee, Chair  
     
Danielle Olds MPH, PhD., RN 
________________________________        
Faculty Project Committee, Co-Chair 
 
 
17 June 2019 
________________________________        








The DNP Project committee for Michele Smith certifies that this is the approved version 
of the following DNP Project: 
Determining Best Practice for Colonoscopy Bowel Preparation in 
Persons with Constipation 
 
 
  Carol Buller DNP, FNP-BC, 
GNP-BC 
 
                                 Chair  
 












Date Approved:  




According to the American Cancer Society, colorectal cancer is estimated to affect 145,000 
people and is expected to cause over 51,000 deaths in the year 2019. The way to prevent 
colorectal cancer is by early detection through colonoscopy starting at age 50 or, age 40 if there 
is a strong family history. To cleanse the bowel for this procedure, patients drink a preparation 
(prep) fluid that induces bowel evacuation. If the preparation is poor, polyps, abnormal tissue, or 
masses can be missed warranting a repeat procedure. The purpose of this project was focused on 
determining the best practice for bowel prep for patients with a history of constipation. The 
project utilized retrospective chart review and assessed the frequency of poor prep diagnoses in 
persons with a history of constipation and association with the type of prep prescribed for 
colonoscopy at two Gastrointestinal (GI) clinic locations associated with a Midwest medical 
center. The overall rate of poor bowel prep was 34% but there was no statistical difference 
between each clinic’s bowel prep practice in the rates of poor prep among this population. This 
project also determined that the current rate of repeat colonoscopy completion due to poor bowel 
prep was 62.5%, 25% of patients at Clinic 1 and 37.5% of patients at Clinic 2. Clinician-
perceived barriers to bowel prep standardization included barriers such as: cost to the patient, 
poor understanding of instructions, and fluid restrictions for comorbidities. The findings from 
this project determined that there is no need for bowel prep standardization across clinic sites 
based on prep, as best practice was not determined based on this project, however, prep should 
be based on patient preference, cost, price, and ability to understand instructions. 
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Determining Best Practice for Colonoscopy Bowel Preparation in Persons with Constipation 
Colorectal cancer is the third most commonly diagnosed cancer in the US (Miller, 
Itzkowitz, Shah, & Jandorf, 2016). The United States Preventative Services Task Force 
(USPSTF) recommends screening for colorectal cancer beginning at age 50, or age 40 for a first 
degree relative with colon cancer (2015). A screening colonoscopy is used to identify abnormal 
growths and polyps, including adenomas which can develop into cancer (Association of 
Directors of Anatomic and Surgical Pathology, 2018). About one-third to one-half of all 
individuals will eventually develop one or more cancerous polyps (adenomas). Early diagnosis 
of colon cancer before it has spread has a 5-year relative survival rate of 90% (American Cancer 
Society, 2018). Screening can also be done with stool-based studies, these studies have an 87% 
specificity while a colonoscopy is considered the gold standard with a specificity rate of 91% 
(Issa & Noureddine, 2017). Individuals with a positive stool-based study are referred for a 
colonoscopy (Cohen, Kastenburg, Mount, & Safdi, 2009, as cited in Kunz & Gillespie, 2017).  
The accuracy of the colonoscopy is largely dependent on the preparation (prep) of the 
colon so lesions can be identified. An incomplete or poor prep leads to missed polyps along with 
the need for repeat colonoscopy requiring a new prep (Lebwohl & Neugut, 2014). For a poor or 
incomplete prep, the Center for Disease and Control and Prevention’s Colorectal Cancer 
Screening Optimizing Quality report recommends repeat screening in 2-6 months (CDC, 2019). 
Research shows the return rate at 18 months due to poor prep is 24.6% (Smith, et al., 2013) and 
the rate for patients to return within three years is under 60% (Menees, et al., 2013).  
Problem 
Nationally, inadequate bowel prep is found in about 20% of colonoscopies with the 
highest rates amid persons with lower socioeconomic status (Lebwohl & Neugut, 2014). 
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Incomplete or poor preps are not only more common in patients in lower socioeconomical 
groups but also in patients with constipation (Cheng, et al., 2017; Corliss, 2017; Lee, et al. 2015; 
Mahmood, Farrooqui, & Madhoun, 2018; Lebwohl & Neugut, 2014). In regard to repeat 
colonoscopy, one study suggests that patients often do not return for the repeat procedure, 
resulting in missed lesions and increased complications (Miller et al., 2016).  
This project took place in a Midwest urban medical center serving a lower socioeconomic 
patient population. There was a perception that persons with constipation had poorer quality 
bowel preps and would have a better-quality result when using a prep that contains more fluid. 
When patients received a diagnosis of “poor prep,” they were ordered to repeat the test within a 
matter of weeks or months. Not only does this result in an additional procedure with the risk of 
anesthesia, but, an additional night of bowel prep, an additional day off work for the procedure, 
and an additional prep which may not be covered by some insurance companies. Repeating the 
procedure due to a poor prep had significant financial implications for this patient population. 
The purpose of this quality improvement project was to determine the best practice in bowel prep 
prior to colonoscopy for patients with a history of constipation. 
Definition 
Poor Bowel Prep 
The definition of poor prep was based on the grading scale used to determine the prep 
quality. The Aronchick scale grades prepping quality according to the amount of gastrointestinal 
lumen visible to the physician. The prep quality is rated as excellent, good, fair, or poor. An 
excellent prepping quality is one in which there is a small volume of clear liquid or more than 
95% of the colonic lumen is seen. A good prepping quality is one in which there is a large 
volume of clear liquid that covers 5%-25% of the surface, but more than 90% of the colonic 
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lumen is seen. A fair prep includes semisolid stool that could be suctioned or washed away but 
more than 90% of the lumen can be seen. And finally, a poor prep includes semisolid stood that 
could not be suctioned or washed away and that less than 90% of the colonic lumen was seen 
(Aronchick et al., 2000, as cited in Kunz & Gillespie, 2017). The operational definition of poor 
prep is defined as the physicians rating according to the Aronchick scale of grading. The 
operational definition was used in this project. 
Literature Review 
Methods 
A review of literature was performed using CINAHL and PubMed. Key words used for 
search engines included: recommended colonoscopy bowel preps, cost of colonoscopy, cost of 
bowel prep for colonoscopy, poor prep diagnosis, repeat colonoscopy completion rate, 
socioeconomic factors and poor prep rates in colonoscopy, and impact of poor prep and 
anesthesia risk. Search limits used included research articles less than eight years old and in the 
English language. Inclusion criteria included research specific to adults (>18 years of age). 
Levels of evidence preference were systematic reviews and randomized clinical control trials 
(RCTs). 
Recommended Pre-Procedure Bowel Preparation 
When patients are referred for a screening colonoscopy, there are several different types 
of prep solution that cleanse the bowel. The two most commonly used preparations at a Midwest 
urban medical center are Nulytely® with Ducolax® and Suprep®. Nulytely® contains 
polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride for oral 
solution, while Suprep® contains sodium sulfate, potassium sulfate, and magnesium sulfate. 
During the literature search of recommended bowel preps, a study was found comparing the 
7 
 
major ingredient in these two bowel preps. The study concluded in over 28,000 colonoscopies 
that sodium-sulfate based preparation solutions (i.e., Suprep®) were recommended for 
community settings due to higher quality bowel preparation (Martin et al., 2016). 
In another study, there was a comparison of patients utilizing Nulytely® and Suprep®. 
The original Nulytely® was used to prep inpatients and the Suprep® was used to prep 
outpatients. The Nulytely®-prepped inpatients had an inadequate bowel prep rate of 44.1% 
compared to the Suprep®-prepped patients’ inadequate bowel prep rate of 16.3% (Corliss, 2017). 
Cost 
The cost of a colonoscopy in 2016, prior to insurance, averaged around $2000 (Sawhney, 
2018). A consumer-based website, the HealthCare Bluebook, lists the average price of 
procedures without insurance, and estimates the cost of a colonoscopy prior to insurance is 
$2285 (CareOperative, 2019). The Affordable Care Act mandates insurance coverage for 
screening colonoscopy, as well as repeat screening colonoscopy due to poor prep as 
recommended by the United States Preventative Task Force (2015).  A poor prep diagnosis 
requiring a repeat procedure is costly to consumers and insurance providers. 
The difference in cost of bowel preps, noted on a consumer-friendly website was 
significant. The Suprep® was listed for over $100 while Nulytely® was listed for $12 (GoodRx, 
2019). Some insurances companies will cover the cost of the prep, while other companies require 
copays and deductibles.  
Repeat colonoscopies also result in increased cost due to anesthesia use. According to a 
study regarding anesthesia use, the quantity of anesthesia used during this procedure increased 
significantly from 2006 to 2015 during colonoscopy procedures. This results in an increased cost 
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of the repeat procedure for all consumers and insurance companies that would not be incurred if 
the bowel prep was initially successful (Krigel et al., 2019).  
Risks of Poor Prep  
Although colonoscopies are low risk procedures, they are not risk free as patients will 
undergo risk of repeat sedation. Complications of a colonoscopy includes bleeding, infection, or 
perforation (Fisher et. al, 2011). The risk of complications after a colonoscopy increases when a 
patient receives anesthesia (Cooper, Kou, & Rex, 2013; Wernli et al., 2016). Complications from 
anesthesia may include aspiration pneumonia, cardiac arrythmias, stroke, or death (Cooper, Kou, 
& Rex, 2013). 
Social Determinants of Health Affecting Colonoscopy 
Lower socioeconomic status (SES) is associated with sub-optimal bowel preparations, 
and persons with a lower SES have increased incidence and mortality rates of colorectal cancer 
(Lebwohl & Neugut, 2014, Mina Suh, et al., 2015). Non-attendance for colonoscopies was 
identified as 42% in this population in one study (Laiyemo et al., 2015). Repeat colonoscopies 
often require another ride, another missed day of work, and another prep. Certain populations are 
more often affected by colorectal cancer than others. According to the CDC, the African 
American population has a higher rate of colorectal cancer at 42.2% per 100,000 people than any 
other race (2016). Reasons for racial or ethnic disparities in colorectal cancer are multifaceted, 
but echo differences in socioeconomic status.  According to the American Cancer Society, 
“People with the least education (used in studies to estimate socioeconomic status) are 40% more 




Constipation and Prep Quality 
The research correlating constipation with poor prep was evident and consistent 
throughout multiple studies. These studies showed that a history of constipation was 
independently associated with inadequate bowel preparation due to diminished or altered bowel 
motility (Cheng, et al., 2017; Corliss, 2017; Lee, et al. 2015; Mahmood, Farrooqui, & Madhoun, 
2018). Results from one study show that sodium phosphate plus bisacodyl was the most effective 
preparation for constipated persons (Pereyra et al., 2013).  
Project Aims 
This purpose of this quality improvement project was to determine the best practice in 
bowel prep prior to colonoscopy for patients with a history of constipation. The project was 
based on the premise that providing an appropriate bowel prep for persons with constipation, 
would reduce the frequency of a diagnosis of poor prep necessitating a repeat colonoscopy. To 
support this purpose, there were three aims met: 
Aim 1: Established the current rate of poor bowel prep (PBP) at each clinic site 
Question 1: What was the current rate of poor bowel prep at each of the clinic 
sites? 
Question 2: Was there a significant difference in rates of poor bowel prep rates 
between the two clinic sites? 
Question 3: Which bowel prep practice (Nulytely® with Ducolax® or  
Suprep®) had lower rates of poor bowel prep? 
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Aim 2: Determined the current rates of repeat screening colonoscopy completion due to 
poor bowel prep at each clinic site 
Question 4: What was the current rate of repeat screening colonoscopy 
completion within one year at each of the clinic sites? 
Question 5: Was there a significant difference in repeat colonoscopy completion 
rates between the two clinic sites? 
 Aim 3: Assessed facilitators and barriers to bowel prep standardization. 
Question 6: What were the facilitators to standardizing the bowel prep practice 
between the two clinic sites? 
Question 7: What were the barriers to standardizing bowel prep practice between 
the two clinic sites? 
Organizational Framework 
The framework for this project incorporated the Institute for Healthcare Improvement’s 
model of Plan-Do-Study-Act (Health Literacy Universal Precautions Toolkit, 2nd Edition, 2015). 
The Plan portion of the model took place with receiving support from team members within the 
organization, IRB review, and project methodology. Team members included the clinic manager, 
the physicians, nurse practitioners, and the nursing staff for both clinics as these groups helped to 
support the research. The Do portion of the model involved the completion of an electronic 
record review and data collection. The Study portion of the model included review, analysis, and 
evaluation of the data. The Act portion of the model used what was learned from the study to 
make recommendations to the stakeholders in the clinic on the most effective preparation for 





The project utilized retrospective chart review and assessed the frequency of poor prep 
diagnoses in persons with a history of constipation and association with the type of prep 
prescribed for colonoscopy at two Gastrointestinal (GI) clinic locations associated with a 
Midwest medical center. From those poor prep diagnoses, a rate of adherence for repeat 
colonoscopy was determined. The operational definition of poor prep diagnosis was used to 
assess the effectiveness of each prep solution based on the Aronchick scale. Clinicians were 
interviewed to determine perceived facilitators and barriers to prep standardization across the 
two clinics.  
Human Subject Protection 
An application was submitted to the Institutional Review Board (IRB) at the University 
of Kansas Medical Center (KUMC) and the IRB at the Midwest medical center prior to any 
project commencement. The KUMC Human Research Protection Program approved the quality 
improvement project and gave the project non-human subject designation. Therefore, the IRB 
and Research Committee at the Midwest medical center were not required to be involved.  Once 
the process of submission for IRB approval and declaration of approval was received, project 
initiation began.  
Human subject and health information was protected using Health Information Privacy 
and Protection (HIPPA) regulations. No patient consent was necessary as this quality 
improvement project was retrospective, no identifiable patient data was collected, and the project 




The setting took place at two GI diagnostic clinics associated with a Midwest medical 
center with two hospital locations. Clinic 1 was located in the main urban hospital campus 
serving a primarily lower socioeconomic population and Clinic 2 was located in the suburban 
hospital campus serving a combination of low socioeconomic and middle-class populations. The 
clinic averaged around 600 procedures per month (400 at Clinic 1 and 200 at Clinic 2). The lead 
physician and a nurse practitioner at the clinic participated in this project.  The nurse practitioner 
assisted in the data collection process. 
When a patient was referred for a screening colonoscopy by their primary care provider, 
a message was sent to the nursing staff of the Gastrointestinal (GI) clinic to order a prep for the 
patient. The prep was ordered by either the nurses working in the clinic or by the nurse 
practitioner, if he or she saw the patient first prior to scheduling the procedure. There was no 
standard prep solution for patients with a history of constipation and information about a history 
of constipation was not routinely passed on to the nursing staff. However, other specific 
information about patients had been passed to the nursing staff through the message system. For 
example, when a patient was on a blood thinning medication the message would include “patient 
is on blood thinner”-warranting special attention or actions. If a patient was seen by a nurse 
practitioner in the GI clinic and scheduled for a screening colonoscopy, the nurse practitioner 
ordered a prep for the patient. The traditional cleansing prep prescribed at the medical center was 
Nulytely®, consisting of 4 liters of solution in combination with 2, 5 mg Ducolax® tablets 
(Nulytley® with Doculax®). The second prep used for about four years, was Suprep®, 
consisting of two 6-ounce bottles of solution. This prep was more commonly prescribed and 
preferred by patients due to the reduced fluid amount when compared to the Nulytely® with 
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Ducolax® amount. At this facility, there were currently no standards for ordering a prep for 
patients with constipation. However, for the last 2-3 years, the Nulytely® with Ducolax® 
preparation had been used exclusively Clinic 1 while the Suprep® had been used more often at 
Clinic 2.  
Sample 
The sample consisted of adults who received a screening colonoscopy, ICD-10-CM code 
Z12.11, and concurrently had a diagnosis of constipation or a past diagnosis of constipation, 
ICD-10-CM code K59.00. 
Data Collection Plan 
A retrospective chart review was used for data collection. The electronic chart review 
began with a search of patients with a current diagnosis (K59.00) or history of constipation and a 
screening colonoscopy between January 2018-July 2018 at both clinic locations. The data 
collection was completed by the project manager (Michele Smith). A yield of 200 patients from 
each clinic was generated. From the 200 charts, 50 patients were randomly selected from each 
clinic using a random number generator. Once a sample from each clinic was identified, the 
following data were collected: prepping solution ordered, the post procedure diagnosis of prep 
quality, the recommendations on when to repeat the colonoscopy, and whether the colonoscopy 
was repeated within the recommended time frame.  
Data were collected regarding facilitators and barriers by interviewing the staff at each 
clinic including nurses, nurse practitioners, and physicians. Questions posed include: 
Question 1: Why was a specific prep ordered at a specific clinic? 
Question 2: Do you feel strongly that one prep works better than the other? 
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Question 3: In your opinion, have patients had an adverse experience with one prep or the 
other? 
Question 4: What do you feel would be a barrier to practice change regarding prep 
ordering habits? 
Instruments. Data were collected on an Excel spread sheet in REDcap, a secure server. 
Facilitator and barrier data were displayed as a word document in REDcap. 
Evaluation Plan 
Pearson’s Chi-square test of independence was used to compare the number of patients 
with poor prep by prep type and by clinic. Of those who received the poor prep diagnosis, a 
percentage of patients who received repeat colonoscopy recommendations and completed a 
repeat colonoscopy within that recommended timeframe was calculated. From this percentage, a 
comparison was made to determine if one clinic has a higher repeat colonoscopy rate than the 
other. Facilitators and barriers were evaluated by comparing and summarizing answers from 
staff.  
Results 
The project was carried out over a two-month period including data collection and 
analysis of data. Of the sample, the total number of patients who experienced excellent prep at 
Clinic 1 was two patients (4.0%) while excellent prep was only experienced by one patient 
(2.0%) at Clinic 2. The majority of patients at Clinic 1 were diagnosed with good prep (22 
patients or 44%), while the majority of patients are Clinic 2 were given a diagnosis of fair prep 
(21 patients or 42%). Only eight patients (16%) experienced a poor prep at Clinic 1 while only 
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nine patients (18%) experienced a poor prep at Clinic 2 (X2 (1, N=100) = 0.07, p=0.79). See 
Table 1. 
Table 1 
Prep Quality by Location 
 Total Excellent 
Prep 
Good Prep Fair Prep Poor Prep 
Clinic 1 50 (50%) 2 (4.0%) 22 (44%) 18 (36%) 8 (16%) 
Clinic 2 50 (50%) 1 (2.0%) 19 (38%) 21 (42%) 9 (18%) 
 
During the 6 months when the sample was collected, Suprep was ordered more often than 
Nulytely. In terms of prepping solution, the most common prep quality grades were good prep or 
fair prep. There was no statistically significant difference in rates of poor prep between the two 
prep solutions ((X2 (1, N=100) = 0.09, p=0.77). See Table 2. 
Table 2 
Prep Quality by Prep Type 
 Total Excellent 
Prep 
Good Prep Fair Prep Poor Prep 
Nulytely 38 (38%) 0 (0%) 18 (4.7%) 13 (3.4%) 7 (1.8%) 




Completion of repeat colonoscopy due to poor prep results varied only slightly by 
location. From the total number of patients, 16 patients (32%) were recommended for repeat 
colonoscopy procedure due to poor prep within one year. Of the eight patients from Clinic 1, 
only two (25%) completed the procedure within the recommended timeframe. Of the eight 
patients from Clinic 2, only three (37.5%) completed the procedure within the recommended 
timeframe. there was no difference in the completion rates between the two clinics (X2 (1, 
N=16) = 0.29, p=0.59) See Table 3. 
Table 3 











Clinic 1 42 (84%) 8 (16%) 2 (25.0%) 
Clinic 2 42 (84%) 8 (16%) 3 (37.5%) 
 
Regarding barriers and facilitators to change of practice, staff at both locations had 
similar answers to posed questions. Five registered nurses and one doctor participated in the 
discussion. The majority of answers to the question of why a specific prep was ordered at a 
specific clinic revolved around financial ability to afford each prep as the patients seen at Clinic 
1 are often of lower socioeconomical status than at Clinic 2. One nurse also states, “That’s just 
what we do” (C.E. personal communication, July 15, 2019). Many of the nurses felt that 
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Nulytely® worked better for patients with constipation due to the required fluid amount 
contained in the dosage when compared to the fluid amount in Suprep®. Regarding adverse 
experiences with one prep over the other, the doctor participating stated, “Suprep is often less 
tolerated due to nausea than the Nulytely” (F.N. personal communication, July 16, 2019). Staff 
agreed that patients often prefer the Suprep however, due to the lesser fluid amount.  
In regards to barriers specific to standardization, the most common answers for this 
question included: poor patient understanding of instructions, patient fluid restriction for some 
comorbidities (i.e. congestive heart failure, renal failure), physicians will not be completely 
supportive unless prep was FDA approved for specific population, a method to assess for 
constipation in patients prior to procedure, and affordability of the prep. Facilitators included 
better patient outcomes with a standardized prep for this population including more time between 
recommended repeat colonoscopies with less frequent exams leading to higher patient 
satisfaction and lower cost to insurance companies. These results were disseminated to the clinic 
stakeholders at the conclusion of the project. 
Discussion 
Of the patients who were referred for a repeat colonoscopy due to poor prep, there was no 
statistical significance in the number of completions per clinic. We found that the frequency of 
poor prep diagnoses at Clinic 1 was similar in number (8) to the frequency of poor prep 
diagnoses at Clinic 2 (9). There was no significant difference in the frequency of poor prep 
dependent on type of prep. 
When compared to the literature, these clinics had a higher rate of adherence with repeat 
colonoscopy recommendations at 31.3% within 12 months, when compared to a study that cited 
a return rate of 24.6% within 18 months (Smith, et al., 2013). In this project there was no 
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statistical significance between the prep with bisacodyl tablets and without bisacodyl tablets 
compared to a study by Pereyra which results showed that sodium phosphate plus bisacodyl 
tablets were more effective in patients with a history of constipation (2013). The results of this 
project showed no statistical significance in type of prep and poor prep rates compared to a study 
by Corliss which showed that the Suprep® had lower poor prep rates (16.3%) than the 
Nulytely® prep (44.1%) (2017).  
In assessing facilitators and barriers, clinicians mentioned that cost was an issue in 
standardizing a bowel prep for this or any specific population as the Nulytely® prep often cost 
around $12 while the Suprep® cost up to $100. Clinicians also felt that many patients would 
prefer to have the Suprep® bowel prep over the Nulytely® bowel prep due to the fluid 
consumption required with Nulytely® at 4 L of fluid while Suprep® is simply 332 milliliters of 
fluid.  
Implications for current practice included using the prep that is cost effective or covered 
by insurance and tolerated by the patient. The next steps for continuous improvement include 
surveying patient preference for the type of prep, common adverse effects from each type of 
prep, other factors influencing poor prep such as certain medications, co-morbidities or health 
literacy, and poor prep rates in this population when compared to non-constipated populations. 
Limitations of this project included the small sample size which was limited within one 
hospital system which inhibits generalizable findings. Another limitation is that, although the 
patients were chosen with the diagnosis of constipation, there was no control of the effects of 
patient characteristics, medications, or other comorbidities. One final limitation is that this was a 
quality improvement project looking at the need for standardizing a prepping solution across the 




In closing, the purpose of the project was to determine if one bowel prep was more 
effective than the other, establish the poor prep rates between the two clinics, and establish 
repeat procedure rates between the two clinics. There was no difference between the two bowel 
preps for this population. We found that there was no difference found in the rates of poor bowel 
prep rates between the two clinic sites. Lastly, we found no difference in the repeat colonoscopy 
completion rates between the two clinic sites. Therefore, there are no recommendations for 
standardizing a bowel prep between these two clinics for this specific population. Further 
recommendations include prescribing bowel prep specific to patient preference. Further 
implications for study include bowel prep preference, adverse effects from each prep, health 
literacy, and other factors that could affect which prep to use in this population when compared 
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